Higher vs. Lower Dose Heparin for PCI (NCT04049591)

🧪 Interventions in This Study

• Higher Dose UFH (DRUG)
• Lower Dose UFH (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Hamilton Health Sciences, General Hospital — Hamilton, Ontario

📞 Contact the Study Coordinator

Phone: (905) 521-2100

Email: HD-PCI@phri.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cardiovascular Diseases

• The Jackson Heart Study of Cardiovascular Disease Among African Americans — Jackson, Mississippi
• Using Big Data to Conduct Innovative Cardiovascular Clinical Trials — Toronto, Ontario
• Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study — Ottawa, Ontario
• Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption — Davis, California
• Black Women's Life Experience On Cardiovascular Health Via Ongoing Monitoring — Arlington, Texas
• Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT) — Baltimore, Maryland

Explore by condition: All Cardiovascular Diseases clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.